PDF herunterladen
Semin Thromb Hemost 2020; 46(05): 545-552
DOI: 10.1055/s-0039-1688492
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Ultrasound Microbubbles for Diagnosis and Treatment of Cardiovascular Diseases

Anne Rix   *
1   Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany
,
Adelina Curaj   *
1   Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany
2   Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany
,
Elisa Liehn
2   Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany
,
Fabian Kiessling
1   Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University, Aachen, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
16. Mai 2019 (online)

    Lizenzen und Reprints

Abstract

Ultrasound (US) imaging of heart and major arteries and veins is among the most frequently used diagnostic techniques applied in humans. Conventional cardiovascular US sessions include anatomical B-mode and functional M-, pulsed-wave- and Doppler mode, which have their limitations in both precise cardiac chambers' delineation and small vessel imaging. The introduction of contrast-enhanced US, employing microbubble suspensions as contrast agent, has enabled a better delineation of heart chambers, the visualization of myocardial microvasculature, and the atherosclerotic plaque neovascularization. Moreover, specific disease-related molecular tracers have been developed by modifying the microbubbles with targeting ligands directed to biological markers exposed to the luminal side of the blood vessels. Microbubble functionalization has enabled in vivo molecular US imaging of various stages of atherosclerosis, from plaque initiation to plaque vulnerability, and neointima formation following revascularization procedures. Furthermore, oscillating microbubbles have been used to mechanically dissolve thrombus material and may act as carriers of drugs and nucleic acids that are released locally by US pulses. This review article summarizes recent advances in functional and molecular US images and discusses therapeutic applications of microbubbles. The addressed topics include an overview on microbubble formats, microbubble detection methods, molecular targets of cardiovascular diseases, and the use of microbubbles for thrombolysis and drug delivery.

Keywords

cardiovascular - microbubbles - molecular imaging - therapeutic ultrasound - ultrasound
 

  • References

  • 1 Laslett LJ, Alagona Jr P, Clark III BA. , et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol 2012; 60 (25) , Suppl): S1 –S49
    CrossrefPubMedGoogle Scholar
  • 2 Mozaffarian D, Benjamin EJ, Go AS. , et al. Heart Disease and Stroke Statistics-2016 Update: A Report from the American Heart Association. Circulation 2016; 133: e38-e360
    PubMedGoogle Scholar
  • 3 Monaghan M, Bhan A. New developments in echocardiography. In: Zamorano JL, Bax JJ, Rademakers FE, Knuuti J. , eds. The ESC Textbook of Cardiovascular Imaging. London: Springer; 2009: 39-72
    Google Scholar
  • 4 Yong Y, Wu D, Fernandes V. , et al. Diagnostic accuracy and cost- effectiveness of contrast echocardiography on evaluation of cardiac function in technically very care unit. Am J Cardiol 2002; 89 (01) 711-718
    CrossrefPubMedGoogle Scholar
  • 5 Brinjikji W, Huston III J, Rabinstein AA, Kim G-M, Lerman A, Lanzino G. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability. J Neurosurg 2016; 124 (01) 27-42
    CrossrefPubMedGoogle Scholar
  • 6 Shah BN, Chahal NS, Kooner JS, Senior R. Contrast-enhanced ultrasonography vs B-mode ultrasound for visualization of intima-media thickness and detection of plaques in human carotid arteries. Echocardiography 2017; 34 (05) 723-730
    CrossrefPubMedGoogle Scholar
  • 7 Rafailidis V, Charitanti A, Tegos T, Destanis E, Chryssogonidis I. Contrast-enhanced ultrasound of the carotid system: a review of the current literature. J Ultrasound 2017; 20 (02) 97-109
    CrossrefPubMedGoogle Scholar
  • 8 Christiansen C, Kryvi H, Sontum PC, Skotland T. Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin. Biotechnol Appl Biochem 1994; 19 (03) 307-320
    PubMedGoogle Scholar
  • 9 Kudo M. Properties of Levovist. In: Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors. Tokyo: Springer Japan; 2003: 15-18
    CrossrefGoogle Scholar
  • 10 Sirsi S, Borden M. Microbubble compositions, properties and biomedical applications. Bubble Sci Eng Technol 2009; 1 (1-2): 3-17
    CrossrefPubMedGoogle Scholar
  • 11 Doinikov AA, Haac JF, Dayton PA. Resonance frequencies of lipid-shelled microbubbles in the regime of nonlinear oscillations. Ultrasonics 2009; 49 (02) 263-268
    CrossrefPubMedGoogle Scholar
  • 12 Kiessling F, Fokong S, Bzyl J, Lederle W, Palmowski M, Lammers T. Recent advances in molecular, multimodal and theranostic ultrasound imaging. Adv Drug Deliv Rev 2014; 72: 15-27
    CrossrefPubMedGoogle Scholar
  • 13 Paul Sidhu AS, Cantisani V, Dietrich CF. , et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) Die EFSUMB-Leitlinien und Empfehlungen für den klinischen Einsatz des kontrastverstärkten Ul. 2018 ;2017:154–180
    PubMed
  • 14 Daeichin V, Van Rooij T, Skachkov I. , et al. Microbubble Composition and Preparation for Imaging: In Vitro and In Vivo Evaluation. 2017; 64 (03) 555-567
    PubMedGoogle Scholar
  • 15 Gong Y, Cabodi M, Porter T. Pressure-dependent resonance frequency for lipid-coated microbubbles at lowacoustic pressures. Proc IEEE Ultrason Symp 2010; 1932-1935
    PubMedGoogle Scholar
  • 16 Curaj A, Wu Z, Fokong S. , et al. Noninvasive molecular ultrasound monitoring of vessel healing after intravascular surgical procedures in a preclinical setup. Arterioscler Thromb Vasc Biol 2015; 35 (06) 1366-1373
    CrossrefPubMedGoogle Scholar
  • 17 Rix A, Fokong S, Heringer S. , et al. Molecular ultrasound imaging of αvβ3-integrin expression in carotid arteries of pigs after vessel injury. Invest Radiol 2016; 51 (12) 767-775
    CrossrefPubMedGoogle Scholar
  • 18 Moccetti F, Weinkauf CC, Davidson BP. , et al. Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress. Ultrasound Med Biol 2018; 44 (06) 1155-1163
    CrossrefPubMedGoogle Scholar
  • 19 Yan P, Chen K-J, Wu J. , et al. The use of MMP2 antibody-conjugated cationic microbubble to target the ischemic myocardium, enhance Timp3 gene transfection and improve cardiac function. Biomaterials 2014; 35 (03) 1063-1073
    CrossrefPubMedGoogle Scholar
  • 20 Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97 (05) 473-483
    CrossrefPubMedGoogle Scholar
  • 21 Fokong S, Siepmann M, Liu Z, Schmitz G, Kiessling F, Gätjens J. Advanced characterization and refinement of poly N-butyl cyanoacrylate microbubbles for ultrasound imaging. Ultrasound Med Biol 2011; 37 (10) 1622-1634
    CrossrefPubMedGoogle Scholar
  • 22 Callot V, Canet E, Brochot J. , et al. Hyperpolarized helium3 encapsulated in microbubbles: a new class of blood pool MRI contrast agent. Acad Radiol 2002; 9 (Suppl (Suppl. 02) S501-S503
    CrossrefPubMedGoogle Scholar
  • 23 Qian L, Thapa B, Hong J. , et al. The present and future role of ultrasound targeted microbubble destruction in preclinical studies of cardiac gene therapy. J Thorac Dis 2018; 10 (Suppl. 02) 1099-1111
    CrossrefPubMedGoogle Scholar
  • 24 Brinjikji W, Huston III J, Rabinstein AA, Kim GM, Lerman A, Lanzino G. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability. J Neurosurg 2016; 124 (01) 27-42
    CrossrefPubMedGoogle Scholar
  • 25 Partovi S, Loebe M, Aschwanden M. , et al. Contrast-enhanced ultrasound for assessing carotid atherosclerotic plaque lesions. AJR Am J Roentgenol 2012; 198 (01) W13-9
    PubMedGoogle Scholar
  • 26 Saha SA, Gourineni V, Feinstein SB. The use of contrast-enhanced ultrasonography for imaging of carotid atherosclerotic plaques: current evidence, future directions. Neuroimaging Clin N Am 2016; 26 (01) 81-96
    CrossrefPubMedGoogle Scholar
  • 27 Wagenaar DJ, Weissleder R, Hengerer A. Glossary of molecular imaging terminology. Acad Radiol 2001; 8 (05) 409-420
    CrossrefPubMedGoogle Scholar
  • 28 Pope JH, Aufderheide TP, Ruthazer R. , et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000; 342 (16) 1163-1170
    CrossrefPubMedGoogle Scholar
  • 29 Lindner JR. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol 2009; 6 (07) 475-481
    PubMedGoogle Scholar
  • 30 Yan Y, Liao Y, Yang L. , et al. Late-phase detection of recent myocardial ischaemia using ultrasound molecular imaging targeted to intercellular adhesion molecule-1. Cardiovasc Res 2011; 89 (01) 175-183
    CrossrefPubMedGoogle Scholar
  • 31 Wu Z, Curaj A, Fokong S. , et al. Rhodamine-loaded intercellular adhesion molecule-1-targeted microbubbles for dual-modality imaging under controlled shear stresses. Circ Cardiovasc Imaging 2013; 6 (06) 974-981
    CrossrefPubMedGoogle Scholar
  • 32 Curaj A, Wu Z, Rix A. , et al. Molecular ultrasound imaging of junctional adhesion molecule a depicts acute alterations in blood flow and early endothelial dysregulation. Arterioscler Thromb Vasc Biol 2018; 38 (01) 40-48
    CrossrefPubMedGoogle Scholar
  • 33 Kaufmann BA, Sanders JM, Davis C. , et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007; 116 (03) 276-284
    CrossrefPubMedGoogle Scholar
  • 34 Sun R, Tian J, Zhang J, Wang L, Guo J, Liu Y. Monitoring inflammation injuries in the progression of atherosclerosis with contrast enhanced ultrasound molecular imaging. PLoS One 2017; 12 (10) e0186155
    CrossrefPubMedGoogle Scholar
  • 35 Fotis L, Agrogiannis G, Vlachos IS. , et al. Intercellular adhesion molecule (ICAM) -1 and vascular cell adhesion molecule (VCAM) -1 at the early stages of atherosclerosis in a rat model. In Vivo 2012; 26: 243-250
    PubMedGoogle Scholar
  • 36 Zhang YJ, Bai DN, Du JX. , et al. Ultrasound-guided imaging of junctional adhesion molecule-A-targeted microbubbles identifies vulnerable plaque in rabbits. Biomaterials 2016; 94: 20-30
    CrossrefPubMedGoogle Scholar
  • 37 Khanicheh E, Mitterhuber M, Xu L, Haeuselmann SP, Kuster GM, Kaufmann BA. Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis. PLoS One 2013; 8 (03) e58761
    CrossrefPubMedGoogle Scholar
  • 38 Yan F, Sun Y, Mao Y. , et al. Ultrasound molecular imaging of atherosclerosis for early diagnosis and therapeutic evaluation through leucocyte-like multiple targeted microbubbles. Theranostics 2018; 8 (07) 1879-1891
    CrossrefPubMedGoogle Scholar
  • 39 Lanza GM, Wallace KD, Scott MJ. , et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996; 94 (12) 3334-3340
    CrossrefPubMedGoogle Scholar
  • 40 Wang X, Gkanatsas Y, Palasubramaniam J. , et al. Thrombus-targeted theranostic microbubbles: a new technology towards concurrent rapid ultrasound diagnosis and bleeding-free fibrinolytic treatment of thrombosis. Theranostics 2016; 6 (05) 726-738
    CrossrefPubMedGoogle Scholar
  • 41 Nederhoed JH, Ebben HP, Slikkerveer J. , et al. Intravenous targeted microbubbles carrying urokinase versus urokinase alone in acute peripheral arterial thrombosis in a porcine model. Ann Vasc Surg 2017; 44: 400-407
    CrossrefPubMedGoogle Scholar
  • 42 Ebben HP, Nederhoed JH, Lely RJ, Wisselink W, Yeung K. ; MUST collaborators. Microbubbles and UltraSound-accelerated Thrombolysis (MUST) for peripheral arterial occlusions: protocol for a phase II single-arm trial. BMJ Open 2017; 7 (08) e014365
    CrossrefPubMedGoogle Scholar
  • 43 Xie F, Gao S, Wu J. , et al. Diagnostic ultrasound induced inertial cavitation to non-invasively restore coronary and microvascular flow in acute myocardial infarction. PLoS One 2013; 8 (07) e69780
    CrossrefPubMedGoogle Scholar
  • 44 Roos ST, Juffermans LJM, van Royen N. , et al. Unexpected high incidence of coronary vasoconstriction in the Reduction of Microvascular Injury Using Sonolysis (ROMIUS) trial. Ultrasound Med Biol 2016; 42 (08) 1919-1928
    CrossrefPubMedGoogle Scholar
  • 45 Zhang L, Sun Z, Ren P. , et al. Localized delivery of shRNA against PHD2 protects the heart from acute myocardial infarction through ultrasound-targeted cationic microbubble destruction. Theranostics 2017; 7 (01) 51-66
    CrossrefPubMedGoogle Scholar
  • 46 He Y, Zhang B, Chen Y. , et al. Image-guided hydrogen gas delivery for protection from myocardial ischemia-reperfusion injury via microbubbles. ACS Appl Mater Interfaces 2017; 9 (25) 21190-21199
    CrossrefPubMedGoogle Scholar
  • 47 Chen G, Yang L, Zhong L. , et al. Delivery of hydrogen sulfide by ultrasound targeted microbubble destruction attenuates myocardial ischemia-reperfusion injury. Sci Rep 2016; 6: 30643
    CrossrefPubMedGoogle Scholar